Nutrition and bipolar disorder: a systematic review

References

• Marx W, Moseley G, Berk M, Jacka F. Nutritional psychiatry: the present state of the evidence. Proc Nutr Soc. 2017 Nov;76(4):427–436. doi:10.1017/S0029665117002026. Epub 2017 Sep 25. PMID: 28942748.
   PubMed Web of Science ®Google Scholar
• Lassale C, Batty GD, Baghdadli A, Jacka F, Sánchez-Villegas A, Kivimäki M, Akbaraly T. Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol Psychiatry. 2019 Jul;24(7):965–986. doi:10.1038/s41380-018-0237-8. Epub 2018 Sep 26. Erratum in: Mol Psychiatry. 2018 Nov 21; Erratum in: Mol Psychiatry. 2021 Jul;26(7):3657. PMID: 30254236; PMCID: PMC6755986.
   PubMed Web of Science ®Google Scholar
• Jacka FN. Nutritional psychiatry: where to next? EBioMedicine. 2017 Mar;17:24–29. doi:10.1016/j.ebiom.2017.02.020. Epub 2017 Feb 21. PMID: 28242200; PMCID: PMC5360575.
   PubMed Web of Science ®Google Scholar
• Chatterton ML, Mihalopoulos C, O'Neil A, Itsiopoulos C, Opie R, Castle D, et al. Economic evaluation of a dietary intervention for adults with major depression (the “SMILES” trial). BMC Public Health. 2018 May 22;18(1):599–610. doi:10.1186/s12889-018-5504-8.
   PubMedGoogle Scholar
• Francis HM, Stevenson RJ, Chambers JR, Gupta D, Newey B, Lim CK. A brief diet intervention can reduce symptoms of depression in young adults – a randomised controlled trial. PLoS One. 2019 Oct 9;14(10):e0222768. doi:10.1371/journal.pone.0222768. PMID: 31596866; PMCID: PMC6784975.
   PubMed Web of Science ®Google Scholar
• Parletta N, Zarnowiecki D, Cho J, Wilson A, Bogomolova S, Villani A, et al. A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: a randomized controlled trial (HELFIMED). Nutr Neurosci. 2019 Jul;22(7):474–487. doi:10.1080/1028415X.2017.1411320. Epub 2017 Dec 7. PMID: 29215971.
   PubMed Web of Science ®Google Scholar
• Segal L, Twizeyemariya A, Zarnowiecki D, Niyonsenga T, Bogomolova S, Wilson A, et al. Cost effectiveness and cost-utility analysis of a group-based diet intervention for treating major depression – the HELFIMED trial. Nutr Neurosci. 2020 Oct;23(10):770–778. doi:10.1080/1028415X.2018.1556896. Epub 2018 Dec 20. PMID: 30570386.
   PubMed Web of Science ®Google Scholar
• Firth J, Teasdale SB, Allott K, Siskind D, Marx W, Cotter J, et al. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry. 2019 Oct;18(3):308–324. doi:10.1002/wps.20672. PMID: 31496103; PMCID: PMC6732706.
   PubMed Web of Science ®Google Scholar
• Sarris J, Logan AC, Akbaraly TN, Amminger GP, Balanzá-Martínez V, Freeman MP, et al. International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry. World Psychiatry. 2015;14(3):370–371. doi:10.1002/wps.20223.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, Hopwood M, Lyndon B, Mulder R, Porter R, Singh AB, Murray G. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021 Jan;55(1):7–117. doi:10.1177/0004867420979353. PMID: 33353391.
   PubMed Web of Science ®Google Scholar
• Platzer M, Fellendorf FT, Bengesser SA, Birner A, Dalkner N, Hamm C, et al. The relationship between food craving, appetite-related hormones and clinical parameters in bipolar disorder. Nutrients. 2020 Dec 29;13(1):76. doi:10.3390/nu13010076. PMID: 33383670; PMCID: PMC7824587.
   PubMed Web of Science ®Google Scholar
• Mansur RB, Lee Y, Subramaniapillai M, Cha DS, Brietzke E, McIntyre RS. Parsing metabolic heterogeneity in mood disorders: a hypothesis-driven cluster analysis of glucose and insulin abnormalities. Bipolar Disord. 2020 Feb;22(1):79–88.
   PubMed Web of Science ®Google Scholar
• Shariq AS, Brietzke E, Rosenblat JD, Barendra V, Pan Z, McIntyre RST. Targeting cytokines in reduction of depressive symptoms: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Apr 20;83:86–91.
   PubMed Web of Science ®Google Scholar
• Lin K, Shao R, Wang R, Lu W, Zou W, Chen K, et al. Brain Behav Immun. 2020 Jan;83:192–199.
   PubMed Web of Science ®Google Scholar
• Lee Y, Mansur RB, Brietzke E, Kapogiannis D, Delgado-Peraza F, Boutilier JJ, et al. Peripheral inflammatory biomarkers define biotypes of bipolar depression. Mol Psychiatry. 2021 Mar 3. doi:10.1038/s41380-021-01051-y.
   Web of Science ®Google Scholar
• Kim HK, Tyryshkin K, Elmi N, Feilotter H, Andreazza AC. Examining redox modulation pathways in the post-mortem frontal cortex in patients with bipolar disorder through data mining of microRNA expression datasets. J Psychiatr Res. 2018 Apr;99:39–49.
   PubMed Web of Science ®Google Scholar
• Brietzke E, Cerqueira RO, Soares CN, Kapczinski F. Is bipolar disorder associated with premature aging? Trends Psychiatry Psychother. 2019 Oct–Dec;41(4):315–317.
   PubMedGoogle Scholar
• Marx W, Lane M, Hockey M, Aslam H, Berk M, Walder K, et al. Diet and depression: exploring the biological mechanisms of action. Mol Psychiatry. 2021 Jan;26(1):134–150. doi:10.1038/s41380-020-00925-x. Epub 2020 Nov 3. PMID: 33144709.
   PubMed Web of Science ®Google Scholar
• Lopresti AL, Jacka FN. Diet and bipolar disorder: a review of its relationship and potential therapeutic mechanisms of action. J Altern Complement Med. 2015;21(12):733–739. doi:10.1089/acm.2015.0125.
   PubMed Web of Science ®Google Scholar
• Beyer JL, Payne ME. Nutrition and bipolar depression. Psychiatr Clin North Am. 2016;39(1):75–86. doi:10.1016/j.psc.2015.10.003.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, et al. Bipolar disorders. Lancet. 2020 Dec 5;396(10265):1841–1856. doi:10.1016/S0140-6736(20)31544-0. PMID: 33278937.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97–170. doi:10.1111/bdi.12609. Epub 2018 Mar 14. PMID: 29536616; PMCID: PMC5947163.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 2021;372:n71. doi:10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Covidence online software. Available from: https://www.covidence.org/reviews/active.
   Google Scholar
• White B. Dietary fatty acids. American Academy of Family Physicians. 2009. Available from: https://www.aafp.org/afp/2009/0815/afp20090815p345.pdf.
   Google Scholar
• Chiu CC, Huang SY, Su KP, Lu ML, Huang MC, Chen CC, Shen WW. Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol. 2003;13(2):99–103. doi:10.1016/s0924-977x(02)00130-x.
   PubMed Web of Science ®Google Scholar
• Sagduyu K, Dokucu ME, Eddy BA, Craigen G, Baldassano CF, Yildiz A. Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study. Nutr J. 2005;4:6. Published 2005 Feb 9. doi:10.1186/1475-2891-4-6.
   PubMed Web of Science ®Google Scholar
• Pomponi M, Janiri L, La Torre G, Di Stasio E, Di Nicola M, Mazza M, et al. Plasma levels of n-3 fatty acids in bipolar patients: deficit restricted to DHA. J Psychiatr Res. 2013;47(3):337–342. doi:10.1016/j.jpsychires.2012.11.004.
   PubMed Web of Science ®Google Scholar
• Saunders EF, Reider A, Singh G, Gelenberg AJ, Rapoport SI. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment. Bipolar Disord. 2015;17(7):729–742. doi:10.1111/bdi.12337.
   PubMed Web of Science ®Google Scholar
• Koga N, Ogura J, Yoshida F, Hattori K, Hori H, Aizawa E, et al. Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder. Transl Psychiatry. 2019;9(1):208. Published 2019 Aug 27. doi:10.1038/s41398-019-0536-0.
   PubMedGoogle Scholar
• Kendirlioglu B, Unalan Ozpercin P, Yuksel Oksuz O, Sozen S, Cihnioglu R, Kalelioglu T, et al. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder. Nord J Psychiatry. 2020;74(2):83–88. doi:10.1080/08039488.2019.167348.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Pandey GN. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 2010;126(1-2):303–311. doi:10.1016/j.jad.2010.03.015.
   PubMed Web of Science ®Google Scholar
• Scola G, Versace A, Metherel AH, Monsalve-Castro LA, Phillips ML, Bazinet RP, Andreazza AC. Alterations in peripheral fatty acid composition in bipolar and unipolar depression. J Affect Disord. 2018;233:86–91. doi:10.1016/j.jad.2017.12.025.
   PubMed Web of Science ®Google Scholar
• Evans SJ, Kamali M, Prossin AR, Harrington GJ, Ellingrod VL, McInnis MG, Burant CF. Association of plasma ω-3 and ω-6 lipids with burden of disease measures in bipolar subjects. J Psychiatr Res. 2012;46(11):1435–1441. doi:10.1016/j.jpsychires.2012.07.016.
   PubMed Web of Science ®Google Scholar
• Evans SJ, Assari S, Harrington GJ, Chang YW, Burant CF, McInnis MG. Plasma linoleic acid partially mediates the association of bipolar disorder on self-reported mental health scales. J Psychiatr Res. 2015;68:61–67. doi:10.1016/j.jpsychires.2015.06.001.
   PubMed Web of Science ®Google Scholar
• Chang YW, Assari S, Prossin AR, Stertz L, McInnis MG, Evans SJ. Bipolar disorder moderates associations between linoleic acid and markers of inflammation. J Psychiatr Res. 2017;85:29–36. doi:10.1016/j.jpsychires.2016.10.021.
   PubMed Web of Science ®Google Scholar
• McInnis MG, Assari S, Kamali M, Ryan K, Langenecker SA, Saunders EFH, et al. Cohort profile: The Heinz C. Prechter longitudinal study of bipolar disorder. Int J Epidemiol. 2018;47(1):28–28n. doi:10.1093/ije/dyx229.
   PubMed Web of Science ®Google Scholar
• Voggt A, Berger M, Obermeier M, Löw A, Seemueller F, Riedel M, et al. Heart rate variability and Omega-3 index in euthymic patients with bipolar disorders. Eur Psychiatry. 2015;30(2):228–232. doi:10.1016/j.eurpsy.2014.11.010.
   PubMed Web of Science ®Google Scholar
• Evans SJ, Prossin AR, Harrington GJ, Kamali M, Ellingrod VL, Burant CF, McInnis MG. Fats and factors: lipid profiles associate with personality factors and suicidal history in bipolar subjects. PLoS One. 2012;7(1):e29297. doi:10.1371/journal.pone.0029297.
   PubMed Web of Science ®Google Scholar
• Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, et al. Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry. 2004;161(10):1922–1924. doi:10.1176/ajp.161.10.1922.
   PubMed Web of Science ®Google Scholar
• Osher Y, Bersudsky Y, Belmaker RH. Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry. 2005 Jun;66(6):726–9. doi:10.4088/jcp.v66n0608. PMID: 15960565.
   PubMed Web of Science ®Google Scholar
• Frangou S, Lewis M, Wollard J, Simmons A. Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol. 2007;21(4):435–439. doi:10.1177/0269881106067787.
   PubMed Web of Science ®Google Scholar
• Keck PE, Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006;60(9):1020–1022. doi:10.1016/j.biopsych.2006.03.056.
   PubMed Web of Science ®Google Scholar
• Murphy BL, Stoll AL, Harris PQ, Ravichandran C, Babb SM, Carlezon WA, Jr, Cohen BM. Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial. J Clin Psychopharmacol. 2012;32(5):699–703. doi:10.1097/JCP.0b013e318266854c.
   PubMed Web of Science ®Google Scholar
• Shakeri J, Khanegi M, Golshani S, Farnia V, Tatari F, Alikhani M, et al. Effects of Omega-3 supplement in the treatment of patients with bipolar I disorder. Int J Prev Med. 2016 May 19;7:77. doi:10.4103/2008-7802.182734. PMID: 27280013; PMCID: PMC4882968.
   PubMedGoogle Scholar
• McNamara RK, Jandacek R, Tso P, Blom TJ, Welge JÁ, Strawn JR, et al. First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: dissociation from clinical response to lithium or quetiapine. Psychiatry Res. 2015;230(2):447–453. doi:10.1016/j.psychres.2015.09.035.
   PubMed Web of Science ®Google Scholar
• Ciappolino V, DelVecchio G, Prunas C, Andreella A, Finos L, Caletti E, et al. The effect of DHA supplementation on cognition in patients with bipolar disorder: an exploratory randomized control trial. Nutrients. 2020 Mar 6;12(3):708. doi:10.3390/nu12030708. PMID: 32155883; PMCID: PMC7146155.
   PubMed Web of Science ®Google Scholar
• McPhilemy G, Byrne F, Waldron M, Hibbeln JR, Davis J, McDonald C, Hallahan B. A 52-week prophylactic randomised control trial of omega-3 polyunsaturated fatty acids in bipolar disorder. Bipolar Disord. 2020 Dec 19. doi:10.1111/bdi.13037. Epub ahead of print. PMID: 33340432.
   Web of Science ®Google Scholar
• Chowdhury MI, Hasan M, Islam MS, Sarwar MS, Amin MN, Uddin SMN, et al. Elevated serum MDA and depleted non-enzymatic antioxidants, macro-minerals and trace elements are associated with bipolar disorder. J Trace Elem Med Biol. 2017;39:162–168. doi:10.1016/j.jtemb.2016.09.012.
   PubMed Web of Science ®Google Scholar
• Pradeep AS, Naga Raju GJ, Sattar SA, Sarita P, Rao ADP, Ray DK, et al. Trace elemental distribution in the scalp hair of bipolars using PIXE technique. Med Hypotheses. 2014;82(4):470–477. doi:10.1016/j.mehy.2014.01.028.
   PubMed Web of Science ®Google Scholar
• Cheng WW, Zhu Q, Zhang HY. Mineral nutrition and the risk of chronic diseases: a Mendelian randomization study. Nutrients. 2019;11(2):378. Published 2019 Feb 12. doi:10.3390/nu11020378.
   PubMed Web of Science ®Google Scholar
• Lyu N, Xing G, Yang J, Zhu X, Zhao X, Zhang L, Wang G. Comparison of inflammatory, nutrient, and neurohormonal indicators in patients with schizophrenia, bipolar disorder and major depressive disorder. J Psychiatr Res. 2021 May;137:401–408. doi:10.1016/j.jpsychires.2021.03.010. Epub 2021 Mar 16. PMID: 33765452.
   PubMed Web of Science ®Google Scholar
• González-Estecha M, Trasobares EM, Tajima K, Cano S, Fernández C, López JL, et al. Trace elements in bipolar disorder. J Trace Elem Med Biol. 2011;25(Suppl 1):S78–S83. doi:10.1016/j.jtemb.2010.10.015.
   PubMed Web of Science ®Google Scholar
• Siwek M, Styczeń K, Sowa-Kućma M, Dudek D, Reczynski W, Szewczyk B, et al. The serum concentration of copper in bipolar disorder. Stężenie miedzi w surowicy w chorobie afektywnej dwubiegunowej. Psychiatr Pol. 2017;51(3):469–481. doi:10.12740/PP/OnlineFirst/65250.
   PubMed Web of Science ®Google Scholar
• Berk M, Williams LJ, Andreazza AC, Pasco JA, Dodd S, Jacka FN, et al. Pop, heavy metal and the blues: secondary analysis of persistent organic pollutants (POP), heavy metals and depressive symptoms in the NHANES national epidemiological survey. BMJ Open. 2014 Jul 1;4(7):e005142.
   PubMed Web of Science ®Google Scholar
• Boerman R, Cohen D, Schulte PF, Nugter A. Prevalence of vitamin D deficiency in adult outpatients with bipolar disorder or schizophrenia. J Clin Psychopharmacol. 2016 Dec;36(6):588–592. doi:10.1097/JCP.0000000000000580. PMID: 27662458.
   PubMed Web of Science ®Google Scholar
• Lapid MI, Drake MT, Geske JR, Mundis CB, Hegard TL, Kung S, Frye MA. Hypovitaminosis D in psychogeriatric inpatients. J Nutr Health Aging. 2013;17(3):231–234. doi:10.1007/s12603-012-0383-7.
   PubMed Web of Science ®Google Scholar
• Behzadi AH, Omrani Z, Chalian M, Asadi S, Ghadiri M. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr Scand. 2009;120(6):441–445. doi:10.1111/j.1600-0447.2009.01368.x.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Montana R, Kinrys G, Deckersbach T, Dufour S, Baek JH. L-Methylfolate for bipolar I depressive episodes: an open trial proof-of-concept registry. J Affect Disord. 2017;207:429–433. doi:10.1016/j.jad.2016.09.053.
   PubMed Web of Science ®Google Scholar
• Russo AJ. Decreased serum hepatocyte growth factor (HGF) in individuals with bipolar disorder normalizes after zinc and anti-oxidant therapy. Nutr Metab Insights. 2010;3:49–55. Published 2010 Oct 19. doi:10.4137/NMI.S5528.
   PubMedGoogle Scholar
• Kaplan BJ, Simpson JS, Ferre RC, Gorman CP, McMullen DM, Crawford SG. Effective mood stabilization with a chelated mineral supplement: an open-label trial in bipolar disorder. J Clin Psychiatry. 2001;62(12):936–944. doi:10.4088/jcp.v62n1204.
   PubMed Web of Science ®Google Scholar
• Marsh WK, Penny JL, Rothschild AJ. Vitamin D supplementation in bipolar depression: a double blind placebo controlled trial. J Psychiatr Res. 2017;95:48–53. doi:10.1016/j.jpsychires.2017.07.021.
   PubMed Web of Science ®Google Scholar
• Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder–a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008 Sep 15;64(6):468–75. doi:10.1016/j.biopsych.2008.04.022. Epub 2008 Jun 5. PMID: 18534556.
   PubMed Web of Science ®Google Scholar
• Berk M, Dean OM, Cotton SM, Hama CS, Kapczinski F, Fernandes B, et al. Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial. BMC Med. 2012;10:91. Published 2012 Aug 14. doi:10.1186/1741-7015-10-91.
   PubMed Web of Science ®Google Scholar
• Berk M, Turner A, Malhi GS, Ng CH, Cotton SM, Dodd S, et al. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo [published correction appears in BMC Med. 2019 Feb 17;17(1):35]. BMC Med. 2019;17(1):18. Published 2019 Jan 25. doi:10.1186/s12916-019-1257-1.
   PubMed Web of Science ®Google Scholar
• Porcu M, Urbano MR, Verri WA, Jr, Barbosa DS, Baracat M, Vargas HO, et al. Effects of adjunctive N-acetylcysteine on depressive symptoms: modulation by baseline high-sensitivity C-reactive protein. Psychiatry Res. 2018 May;263:268–274. doi:10.1016/j.psychres.2018.02.056. Epub 2018 Mar 13. PMID: 29605103.
   PubMed Web of Science ®Google Scholar
• Bauer IE, Green C, Colpo GD, Teixeira AL, Selvaraj S, Durkin K, et al. A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression. J Clin Psychiatry. 2018 Dec 4;80(1):18m12200. doi:10.4088/JCP.18m12200. PMID: 30549489.
   PubMed Web of Science ®Google Scholar
• Nery FG, Li W, DelBello MP, Welge JA. N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials. Bipolar Disord. 2020 Dec 22. doi:10.1111/bdi.13039. Epub ahead of print. PMID: 33354859.
   Web of Science ®Google Scholar
• Noaghiul S, Hibbeln JR. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry. 2003;160(12):2222–2227. doi:10.1176/appi.ajp.160.12.2222.
   PubMed Web of Science ®Google Scholar
• Noguchi R, Hiraoka M, Watanabe Y, Kagawa Y. Relationship between dietary patterns and depressive symptoms: difference by gender, and unipolar and bipolar depression. J Nutr Sci Vitaminol (Tokyo). 2013;59(2):115–122. doi:10.3177/jnsv.59.115.
   PubMed Web of Science ®Google Scholar
• Łojko D, Stelmach-Mardas M, Suwalska A. Diet quality and eating patterns in euthymic bipolar patients. Eur Rev Med Pharmacol Sci. 2019;23(3):1221–1238. doi:10.26355/eurrev_201902_17016.
   PubMed Web of Science ®Google Scholar
• Kilbourne AM, Rofey DL, McCarthy JF, Post EP, Welsh D, Blow FC. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord. 2007;9(5):443–452. doi:10.1111/j.1399-5618.2007.00386.x.
   PubMed Web of Science ®Google Scholar
• Maremmani I, Perugi G, Rovai L, Maremmani AGI, Pacini M, Canonico PL, et al. Are “social drugs” (tobacco, coffee and chocolate) related to the bipolar spectrum? J Affect Disord. 2011;133(1-2):227–233. doi:10.1016/j.jad.2011.04.019.
   PubMed Web of Science ®Google Scholar
• Almeida OP, Hankey GJ, Yeap BB, Flicker L. Impact of a prudent lifestyle on the clinical outcomes of older men with bipolar disorder. Aging Ment Health. 2020 Apr;24(4):627–633. doi:10.1080/13607863.2018.1553233. Epub 2018 Dec 31. PMID: 30596455.
   PubMed Web of Science ®Google Scholar
• Hunjan AK, Hübel C, Lin Y, Eley TC, Breen G. Association between polygenic propensity for psychiatric disorders and nutrient intake. Commun Biol. 2021 Aug 26;4(1):965. doi:10.1038/s42003-021-02469-4. PMID: 34446809; PMCID: PMC8390493.
   PubMed Web of Science ®Google Scholar
• Bly MJ, Taylor SF, Dalack G, Pop-Busui R, Burghardt KJ, Evans SJ, et al. Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population. Bipolar Disord. 2014;16(3):277–288. doi:10.1111/bdi.12160.
   PubMed Web of Science ®Google Scholar
• Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry. 2001;62(6):486–493. doi:10.4088/jcp.v62n0614.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Gennusa JV 3rd, Stallings C, Origoni A, Katsafanas E, Sweeney K, et al. Protein intake is associated with cognitive functioning in individuals with psychiatric disorders. Psychiatry Res. 2020 Feb;284:112700. doi:10.1016/j.psychres.2019.112700. Epub 2019 Nov 22. PMID: 31791705.
   PubMed Web of Science ®Google Scholar
• Evans SJ, Ringrose RN, Harrington GJ, Mancuso P, Burant CF, McInnis MG. Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism. J Psychiatr Res. 2014;57:58–64. doi:10.1016/j.jpsychires.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Mehrpooya M, Yasrebifar F, Haghighi M, Mohammadi Y, Jahangard L. Evaluating the effect of Coenzyme Q10 augmentation on treatment of bipolar depression: a double-blind controlled clinical trial. J Clin Psychopharmacol. 2018;38(5):460–466. doi:10.1097/JCP.0000000000000938.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, et al. Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial. Bipolar Disord. 2018;20(7):614–621. doi:10.1111/bdi.12652.
   PubMed Web of Science ®Google Scholar
• Eslami Shahrbabaki M, Sabouri S, Sabahi A, Barfeh D, Divsalar P, Esmailzadeh M, Ahmadi A. The efficacy of probiotics for treatment of bipolar disorder-type 1: a randomized, double-blind, placebo controlled trial. Iran J Psychiatry. 2020 Jan;15(1):10–16. PMID: 32377210; PMCID: PMC7193240.
   PubMedGoogle Scholar
• Reininghaus EZ, Wetzlmair LC, Fellendorf FT, Platzer M, Queissner R, Birner A, et al. Probiotic treatment in individuals with euthymic bipolar disorder: a pilot-study on clinical changes and compliance. Neuropsychobiology. 2020;79(1):71–79. doi:10.1159/000493867. Epub 2018 Oct 19. PMID: 30343291.
   PubMed Web of Science ®Google Scholar
• zElmslie JL, Porter RJ, Joyce PR, Hunt PJ, Mann JI. Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet. Bipolar Disord. 2006;8(5 Pt 1):503–507. doi:10.1111/j.1399-5618.2006.00345.x.
   PubMed Web of Science ®Google Scholar
• Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG, Jr, et al. A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol. 2013;33(5):627–635. doi:10.1097/JCP.0b013e31829a83f5.
   PubMed Web of Science ®Google Scholar
• Toniolo RA, Silva M, Fernandes FBF, Amaral JAMS, Dias RDS, Lafer B. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression. J Neural Transm (Vienna). 2018;125(2):247–257. doi:10.1007/s00702-017-1817-5.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163(2):210–216. doi:10.1176/appi.ajp.163.2.210.
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. An increase in the Omega-6/Omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128. Published 2016 Mar 2. doi:10.3390/nu8030128.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio JJ, O'Keefe JH. Importance of maintaining a low omega-6/omega-3 ratio for reducing inflammation. Open Heart. 2018;5(2):e000946. Published 2018 Nov 26. doi:10.1136/openhrt-2018-000946.
   PubMed Web of Science ®Google Scholar
• Berger ME, Smesny S, Kim SW, Davey CG, Rice S, Sarnyai Z, et al. Omega-6 to Omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study. Transl Psychiatry. 2017;7(8):e1220. Published 2017 Aug 29. doi:10.1038/tp.2017.190.
   PubMedGoogle Scholar
• Choque B, Catheline D, Rioux V, Legrand P. Linoleic acid: between doubts and certainties. Biochimie. 2014;96:14–21. doi:10.1016/j.biochi.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Tur JA, Bibiloni MM, Sureda A, Pons A. Dietary sources of omega 3 fatty acids: public health risks and benefits. Br J Nutr. 2012 Jun;107(Suppl 2):S23–52. doi:10.1017/S0007114512001456. PMID: 22591897.
   PubMedGoogle Scholar
• Panagiotakos DB, Kastorini CM, Pitsavos C, Stefanadis C. The current Greek diet and the omega-6/omega-3 balance: the Mediterranean diet score is inversely associated with the omega-6/omega-3 ratio. World Rev Nutr Diet. 2011;102:53–56. doi:10.1159/000327791.
   PubMedGoogle Scholar
• Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, Labadarios D. Blood vitamin concentrations during the acute-phase response. Crit Care Med. 1992;20:934–941.
   PubMed Web of Science ®Google Scholar
• Shikora S, Martindale R, Nishikawa R, Siepler J. The metabolic response to stress and alterations in nutrient metabolism. In: Shikora S, Martindale R, Schwaitzberg S, editors. Nutritional considerations in the intensive care unit: science, rationale and practice. Kendall Hunt; Dubuque, Iowa 2002. p. 139–152.
   Google Scholar
• Jones BDM, Daskalakis ZJ, Carvalho AF, Strawbridge R, Young AH, Mulsant BH, Husain MI. Inflammation as a treatment target in mood disorders: review. BJPsych Open. 2020 Jun 5;6(4):e60. doi:10.1192/bjo.2020.43. PMID: 32498754; PMCID: PMC7345526.
   PubMed Web of Science ®Google Scholar
• Messamore E, Almeida DM, Jandacek RJ, McNamara RK. Polyunsaturated fatty acids and recurrent mood disorders: phenomenology, mechanisms, and clinical application. Prog Lipid Res. 2017 Apr;66:1–13. doi:10.1016/j.plipres.2017.01.001. Epub 2017 Jan 6. PMID: 28069365; PMCID: PMC5422125.
   PubMed Web of Science ®Google Scholar
• Jacka FN, Cherbuin N, Anstey KJ, Butterworth P. Dietary patterns and depressive symptoms over time: examining the relationships with socioeconomic position, health behaviours and cardiovascular risk. PLoS One. 2014 Jan 29;9(1):e87657. doi:10.1371/journal.pone.0087657. PMID: 24489946; PMCID: PMC3906192.
   PubMed Web of Science ®Google Scholar
• Lichtenstein AH, Russell RM. Essential nutrients: food or supplements? Where should the emphasis be? JAMA. 2005 Jul 20;294(3):351–8. doi:10.1001/jama.294.3.351. PMID: 16030280.
   PubMed Web of Science ®Google Scholar
• Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M, et al. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosom Med. 2019 Apr;81(3):265–280. doi:10.1097/PSY.0000000000000673. Erratum in: Psychosom Med. 2020 Jun;82(5):536. Erratum in: Psychosom Med. 2021 Feb-Mar 01;83(2):196. PMID: 30720698; PMCID: PMC6455094.
   PubMed Web of Science ®Google Scholar
• Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017 Jan 30;15(1):23. doi:10.1186/s12916-017-0791-y. Erratum in: BMC Med. 2018 Dec 28;16(1):236. PMID: 28137247; PMCID: PMC5282719.
   PubMed Web of Science ®Google Scholar
• Maguire Á, Hargreaves A, Gill M. Coenzyme q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia [published online ahead of print, 2018 Dec 12]. Nutr Neurosci. 2018: 1–14. doi:10.1080/1028415X.2018.1556481.
   Web of Science ®Google Scholar
• Vindegaard N, Speyer H, Nordentoft M, Rasmussen S, Benros ME. Gut microbial changes of patients with psychotic and affective disorders: a systematic review [published online ahead of print, 2020 Jan 14]. Schizophr Res. 2020;S0920-9964(19):30584–5. doi:10.1016/j.schres.2019.12.014.
   Google Scholar
• Stelmach E, Romanowski M, Olajossy M. The role of acetyl-L-carnitine (LAC) in the treatment of mental disorders. Curr Probl Psychiatry. 2019;20(4). doi:10.2478/cpp-2019-0017.
   Google Scholar
• Kious BM, Kondo DG, Renshaw PF. Creatine for the treatment of depression. Biomolecules. 2019;9(9):406. Published 2019 Aug 23. doi:10.3390/biom9090406.
   PubMed Web of Science ®Google Scholar
• Hsieh YC, Chou LS, Lin CH, Wu HC, Li DJ, Tseng PT. Serum folate levels in bipolar disorder: a systematic review and meta-analysis. BMC Psychiatry. 2019;19(1):305. Published 2019 Oct 22. doi:10.1186/s12888-019-2269-2.
   PubMed Web of Science ®Google Scholar
• Silva VC, Oliveira AC, D’Almeida V. Homocysteine and psychiatric disorders. J Inborn Errors Metab Screen. 2017. doi:10.1177/232640981770147.
   PubMedGoogle Scholar
• Grønli O, Kvamme JM, Friborg O, Wynn R. Zinc deficiency is common in several psychiatric disorders. PLoS One. 2013;8(12):e82793. doi:10.1371/journal.pone.0082793.
   PubMed Web of Science ®Google Scholar
• Petrilli MA, Kranz TM, Kleinhaus K, Joe P, Getz M, Johnson P, et al. The emerging role for zinc in depression and psychosis. Front Pharmacol. 2017;8:414. doi:10.3389/fphar.2017.00414.
   PubMed Web of Science ®Google Scholar
• Piao M, Cong X, Feng C, Ge P. The role of zinc in mood disorders. Neuropsychiatry. 2017;7(4):378–386.
   Google Scholar
• Styczeń K, Sowa-Kućma M, Siwek M, Dudek D, Reczynski W, Misztak P, et al. Study of the serum copper levels in patients with major depressive disorder. Biol Trace Elem Res. 2016;174(2):287–293. doi:10.1007/s12011-016-0720-5.
   PubMed Web of Science ®Google Scholar
• Malavolta M, Piacenza F, Basso A, Giacconi R, Costarelli L, Mocchegiani E. Serum copper to zinc ratio: relationship with aging and health status. Mech Ageing Dev. 2015;151:93–100. doi:10.1016/j.mad.2015.01.004.
   PubMed Web of Science ®Google Scholar
• Levitt AJ, Joffe RT. Folate, B12, and life course of depressive illness. Biol Psychiatry. 1989;25:867–872.
   PubMed Web of Science ®Google Scholar
• Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry. 1982;141:87–89.
   PubMed Web of Science ®Google Scholar
• Carney MW, Chary TK, Laundy M, Bottiglieri T, Chanarin I, Reynolds EH, Toone B. Red cell folate concentrations in psychiatric patients. J Affect Disord. 1990;19:207–213.
   PubMed Web of Science ®Google Scholar
• Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry. 1997;42:349–358.
   PubMed Web of Science ®Google Scholar
• McLoughlin IJ, Hodge JS. Zinc in depressive disorder. Acta Psychiatr Scand. 1990;82:451–453.
   PubMed Web of Science ®Google Scholar
• Głąbska D, Guzek D, Groele B, Gutkowska K. Fruit and vegetable intake and mental health in adults: A systematic review. Nutrients. 2020;12(1):115. Published 2020 Jan 1. doi:10.3390/nu12010115.
   PubMed Web of Science ®Google Scholar
• Gangwisch JE, Hale L, Garcia L, Malaspina D, Opler M, Payne ME, et al. High glycemic index diet as a risk factor for depression: analyses from the women's health initiative. Am J Clin Nutr. 2015;102(2):454–463. doi:10.3945/ajcn.114.103846.
   PubMed Web of Science ®Google Scholar
• Gibson-Smith D, Bot M, Brouwer IA, Visser M, Giltay EJ, Penninx BWJH. Association of food groups with depression and anxiety disorders. Eur J Nutr. 2020;59(2):767–778. doi:10.1007/s00394-019-01943-4.
   PubMed Web of Science ®Google Scholar
• Ashton MM, Dean OM, Marx W, Mohebbi M, Berk M, Malhi GS, et al. Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: a sub-study of a randomised placebo-controlled trial. Aust N Z J Psychiatry. 2020 Feb;54(2):159–172. doi:10.1177/0004867419882497. Epub 2019 Oct 29. PMID: 31661974.
   PubMed Web of Science ®Google Scholar
• Tello M. Diet and depression. Harvard Health Blog. 2020.
   Google Scholar
• Sylvia LG, Pegg SL, Dufour SC, Janos JA, Bernstein EE, Chang WC, et al. Pilot study of a lifestyle intervention for bipolar disorder: nutrition exercise wellness treatment (NEW Tx). J Affect Disord. 2019 May 1;250:278–283. doi:10.1016/j.jad.2019.03.033. Epub 2019 Mar 6. PMID: 30875669; PMCID: PMC7676479.
   PubMed Web of Science ®Google Scholar
• Ronis MJJ, Pedersen KB, Watt J. Adverse effects of nutraceuticals and dietary supplements. Annu Rev Pharmacol Toxicol. 2018;58:583–601. doi:10.1146/annurev-pharmtox-010617-052844.
   PubMed Web of Science ®Google Scholar
• Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis. 2014;34:172–193. doi:10.1055/s-0034-1375958.
   PubMed Web of Science ®Google Scholar
• Yanik M, Vural H, Tutkun H, Zoroglu SS, Savas HA, Herken H, et al. The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur Arch Psychiatry Clinical Neurosci. 2004;254:43–47. doi:10.1007/s00406-004-0453-x.
   PubMed Web of Science ®Google Scholar
• Rakofsky JJ, Dunlop BW. Review of nutritional supplements for the treatment of bipolar depression. Depress Anxiety. 2014 May;31(5):379–90. doi:10.1002/da.22220. Epub 2013 Dec 18. PMID: 24353094.
   PubMed Web of Science ®Google Scholar